Chronic Kidney Disease with Secondary Hyperparathyroidism
This patient has secondary hyperparathyroidism due to chronic kidney disease (CKD), evidenced by severe hypocalcemia (5.8 mg/dL) with an appropriately elevated PTH (274 pg/mL) and normal magnesium.
Pathophysiology
The combination of severe hypocalcemia with elevated PTH indicates the parathyroid glands are functioning appropriately—they are responding to low calcium by secreting more PTH. This is the hallmark of secondary hyperparathyroidism, not primary hypoparathyroidism 1.
In CKD, three interconnected mechanisms drive this picture:
Reduced 1,25(OH)₂D production: Failing kidneys cannot adequately convert 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D, leading to decreased intestinal calcium absorption and direct impairment of PTH suppression 1
Phosphate retention: Even before overt hyperphosphatemia develops, transient phosphate retention directly decreases ionized calcium and stimulates PTH secretion 1
Skeletal resistance to PTH: The bones become less responsive to PTH's calcium-mobilizing effects, perpetuating hypocalcemia 1
Why This Is NOT Hypoparathyroidism
The PTH level of 274 pg/mL is the critical distinguishing feature. In true hypoparathyroidism, PTH would be inappropriately low or undetectable in the setting of hypocalcemia 2, 3. Here, the PTH is elevated and appropriate for the degree of hypocalcemia—the parathyroid glands are working overtime trying to correct the low calcium 1.
Magnesium's Role
The normal magnesium is important because severe hypomagnesemia can cause a functional hypoparathyroid state with low PTH and hypocalcemia that mimics true hypoparathyroidism 4, 5. Magnesium deficiency impairs both PTH secretion and end-organ responsiveness to PTH 5. Since magnesium is normal here, this mechanism is excluded.
Essential Next Steps
Immediately assess kidney function (serum creatinine, eGFR) and serum phosphorus 1, 6. The PTH level of 274 pg/mL falls within the target range (150-300 pg/mL) for dialysis patients but would be markedly elevated for someone with normal kidney function 1.
Check 25-hydroxyvitamin D levels to identify vitamin D deficiency, which commonly coexists and exacerbates secondary hyperparathyroidism 2.
Clinical Context
If this patient has CKD stage G3a-G5D, the elevated PTH represents an adaptive response to maintain calcium-phosphate homeostasis 1. The parathyroid glands enlarge and increase PTH secretion to compensate for reduced kidney function, decreased vitamin D activation, and impaired calcium absorption.
Common pitfall: Do not treat this as primary hypoparathyroidism by simply replacing calcium and vitamin D without addressing the underlying kidney disease. The management strategy differs fundamentally—CKD-related secondary hyperparathyroidism requires active vitamin D sterols (calcitriol, paricalcitol, or doxercalciferol), phosphate management, and potentially calcimimetics if PTH rises further 1, 6.